Study finds a marijuana derivative might reduce seizure frequency and may be safe for use in treatment-resistant epilepsy.
Adam Rifkin stashed this in Medicine
Stashed in: Marijuana
To save this post, select a stash from drop-down menu or type in a new one:
Interpretation:
Our findings suggest that cannabidiol might reduce seizure frequency and might have an adequate safety profile in children and young adults with highly treatment-resistant epilepsy. Randomised controlled trials are warranted to characterise the safety profile and true efficacy of this compound.
Paper:
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
10:04 PM Jan 02 2016